Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
PATTERSON, N.Y., June 7, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that Glass Lewis & Co. LLC, a leading independent governance analysis and proxy voting...
-
Company has Created Shareholder Value, While Election of Dissident Slate Could Disrupt Progress Control of the Board and Company are at Stake PATTERSON, N.Y., June 2, 2010 (GLOBE NEWSWIRE) --...
-
Company Has Created Shareholder Value by Executing Focused Business Plan Win by Tang/Edelman Would Give Dissidents Board Control PATTERSON, N.Y., May 17, 2010 (GLOBE NEWSWIRE) -- Penwest...
-
Posts Third Consecutive Profitable Quarter Opana ER Royalty From Endo Now Being Paid at Full Rate PATTERSON, N.Y., May 3, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today...
-
PATTERSON, N.Y., April 26, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) will conduct a conference call on Monday, May 3, at 10:00 a.m. EDT to review its financial results for the...
-
Company Successfully Executing Focused Business Plan; Delivering Profitability and Gains in Shareholder Value Anticipates Proxy Contest in Connection with June 22 Annual Meeting PATTERSON,...
-
PATTERSON, N.Y., April 13, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals (Nasdaq:PPCO) and Endo Pharmaceuticals (Nasdaq:ENDP) announced today that the companies have settled litigation with Barr...
-
PATTERSON, N.Y., April 9, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has signed a drug development and commercialization agreement with Alvogen, Inc....
-
Posts Second Consecutive Profitable Quarter Outlines Guidance and Business Plan Goals for 2010 Announces Intent to Pay Special Cash Dividend in Fourth Quarter 2010 PATTERSON, N.Y., March 4,...
-
PATTERSON, N.Y., March 3, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that Jennifer Good, President and Chief Executive Officer of Penwest, will be presenting at...